STEPHEN SENENKO: Open Payments
NPI 1164784542 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 58 payments from 18 companies in 2025. Trend: 2023 $340 · 2024 $983 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $284 |
| Novo Nordisk Inc | 12 | $195 |
| Gilead Sciences, Inc. | 5 | $117 |
| Exact Sciences Corporation | 4 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| SHIELD THERAPEUTICS INC | 4 | $72 |
| PFIZER INC. | 4 | $69 |
| GlaxoSmithKline, LLC. | 2 | $58 |
| Lilly USA, LLC | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
Products named: Kerendia, Cologuard Collection Kit, CAPLYTA, Rybelsus, ACCRUFER, TRELEGY ELLIPTA, MOUNJARO, SPRAVATO.
Industry payments across NY — which companies pay providers there.
